Dr. Daniel W. Weed
Claim this profileCommunity Cancer Center East
Studies Breast Cancer
Studies Breast cancer
7 reported clinical trials
16 drugs studied
Area of expertise
1Breast Cancer
ER positive
Stage II
Stage I
2Breast Cancer
ER positive
Affiliated Hospitals
Clinical Trials Daniel W. Weed is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
More about Daniel W. Weed
Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Daniel W. Weed has experience with
- Atezolizumab
- Hypofractionated Radiation Therapy
- Radiation Therapy
- Local Consolidation Therapy
- Partial Breast Irradiation
- No Radiation
Breakdown of trials Daniel W. Weed has run
Breast Cancer
Breast cancer
Lung Cancer
Malignant Solid Neoplasm
Lobular Carcinoma in Situ
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel W. Weed specialize in?
Daniel W. Weed focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved ER positive patients, or patients who are Stage II.
Is Daniel W. Weed currently recruiting for clinical trials?
Yes, Daniel W. Weed is currently recruiting for 2 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Daniel W. Weed has studied deeply?
Yes, Daniel W. Weed has studied treatments such as Atezolizumab, Hypofractionated Radiation Therapy, Radiation Therapy.
What is the best way to schedule an appointment with Daniel W. Weed?
Apply for one of the trials that Daniel W. Weed is conducting.
What is the office address of Daniel W. Weed?
The office of Daniel W. Weed is located at: Community Cancer Center East, Indianapolis, Indiana 46219 United States. This is the address for their practice at the Community Cancer Center East.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.